PHARMACEUTICAL STATISTICS

Scope & Guideline

Transforming Data into Knowledge in Pharmaceutical Sciences

Introduction

Explore the comprehensive scope of PHARMACEUTICAL STATISTICS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore PHARMACEUTICAL STATISTICS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1539-1604
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationPHARM STAT / Pharm. Stat.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Pharmaceutical Statistics' is dedicated to the dissemination of innovative statistical methodologies and their applications in the pharmaceutical and clinical research fields. It focuses on enhancing the design, analysis, and interpretation of clinical trials and other biomedical studies through rigorous statistical frameworks.
  1. Innovative Statistical Methodologies:
    The journal emphasizes the development and application of novel statistical techniques tailored for clinical trials, including Bayesian methods, adaptive designs, and machine learning approaches.
  2. Clinical Trial Design and Analysis:
    A core focus is on optimizing clinical trial designs, such as multi-arm and multi-stage trials, to improve efficiency and decision-making in drug development.
  3. Pharmacokinetics and Pharmacodynamics:
    Research often includes the statistical analysis of pharmacokinetic and pharmacodynamic data, addressing how drugs affect the body and vice versa, which is critical in drug development.
  4. Real-World Evidence and Data Integration:
    The journal explores methodologies for integrating real-world data into clinical trial designs, enhancing the relevance and applicability of trial results in broader populations.
  5. Patient-Reported Outcomes and Quality of Life:
    It also covers statistical methods for analyzing patient-reported outcomes, focusing on how treatments impact patients' quality of life and their overall treatment experience.
The journal exhibits a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent years. These trends highlight the journal's responsiveness to contemporary challenges in pharmaceutical research and statistics.
  1. Bayesian Adaptive Designs:
    There is a significant increase in research on Bayesian adaptive trial designs, which offer flexibility in modifying trial parameters based on interim results, thereby enhancing decision-making during clinical trials.
  2. Machine Learning Applications:
    The integration of machine learning techniques into statistical methodologies is on the rise, particularly for predicting treatment outcomes and analyzing complex datasets, reflecting the industry's push towards data-driven approaches.
  3. Real-World Evidence Utilization:
    The use of real-world evidence in clinical trial designs and post-marketing surveillance is becoming more prominent, emphasizing the need to understand how treatments perform in broader, more diverse patient populations.
  4. Patient-Centric Approaches:
    There is a growing emphasis on patient-centered methodologies, particularly in analyzing patient-reported outcomes and incorporating patient preferences into trial designs, which aligns with the broader movement towards personalized medicine.
  5. Hybrid Clinical Trials:
    Research on hybrid clinical trial designs that combine elements of traditional randomized controlled trials with real-world data is emerging, indicating a shift towards more innovative and adaptable research frameworks.

Declining or Waning

While 'Pharmaceutical Statistics' continues to thrive in various areas, certain themes appear to be losing prominence in recent publications. These declining scopes reflect shifts in research focus and methodological preferences within the field.
  1. Traditional Frequentist Approaches:
    There is a noticeable decline in the emphasis on traditional frequentist statistical methods. The growing preference for Bayesian approaches suggests a shift towards more flexible modeling frameworks that can incorporate prior information.
  2. Single-Endpoint Trials:
    Research focused solely on single endpoints in clinical trials is becoming less common, with a trend towards multi-endpoint designs that provide a more comprehensive evaluation of treatment effects.
  3. Basic Statistical Theory:
    Publications that delve deeply into basic statistical theory without direct application to practical problems are waning, as the field increasingly favors applied methodologies and real-world applications.
  4. Conventional Data Handling Techniques:
    The use of conventional data handling methods, such as simple imputation techniques, is decreasing in favor of more advanced approaches that address complexities in missing data and incorporate machine learning techniques.

Similar Journals

International Journal of Biostatistics

Bridging Theory and Practice in Health Statistics.
Publisher: WALTER DE GRUYTER GMBHISSN: 2194-573XFrequency: 2 issues/year

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS

Elevating Research Standards in Statistical Theory
Publisher: SPRINGER HEIDELBERGISSN: 0020-3157Frequency: 5 issues/year

ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, published by SPRINGER HEIDELBERG, is a prestigious academic journal that has played a pivotal role in the field of statistical mathematics since its inception in 1949. With a focus on advancing research in statistics and probability, this journal is ranked in the Q2 quartile for 2023, indicating its significance and impact within the academic community. Researchers and professionals engaged in statistical theory and methodology will find the journal's comprehensive coverage of contemporary issues essential for furthering their work and understanding of the discipline. The journal is accessible in print and digital formats, facilitating wide dissemination of knowledge among its readership. With a history of rigorous peer review and a commitment to high-quality research, the ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS continues to be a vital resource for academics and practitioners alike.

STATISTICAL METHODS IN MEDICAL RESEARCH

Elevating health research with cutting-edge statistical techniques.
Publisher: SAGE PUBLICATIONS LTDISSN: 0962-2802Frequency: 6 issues/year

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

Statistics in Biopharmaceutical Research

Pioneering methodologies for the future of drug development.
Publisher: TAYLOR & FRANCIS INCISSN: 1946-6315Frequency: 4 issues/year

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

Korean Journal of Applied Statistics

Empowering Researchers with Rigorous Statistical Insights
Publisher: KOREAN STATISTICAL SOCISSN: 1225-066XFrequency: 6 issues/year

Korean Journal of Applied Statistics, published by the Korean Statistical Society, is a prominent journal dedicated to advancing the field of applied statistics. ISSN 1225-066X (Print) and E-ISSN 2383-5818 (Online), this journal serves as a vital platform for disseminating high-quality research that addresses the latest methodologies, applications, and innovations in statistical practices. Though currently not an open-access journal, it aims to foster collaboration among statisticians, researchers, and practitioners by providing rigorous peer-reviewed articles that enhance understanding and application of statistical techniques across various disciplines. With a commitment to integrating theory and practice, the Korean Journal of Applied Statistics stands as a crucial resource for those seeking to influence the evolving landscape of statistical research and its applications in Korea and beyond.

Trials

Fostering innovation in medicine through rigorous trials.
Publisher: BMCISSN: Frequency: 1 issue/year

Trials, published by BMC, is a leading open access journal that has been pioneering advancements in the field of medicine and pharmacology since its inception in 2006. With an impressive E-ISSN of 1745-6215, the journal is based in the United Kingdom and operates from its address at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND. Trials is recognized for its impactful contributions to the research community, achieving a Q2 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories according to the 2023 category quartiles. This esteemed journal aims to provide a platform for presenting cutting-edge clinical trials and methodological advances, effectively fostering collaboration and innovation among researchers, professionals, and students. The journal's accessibility, supported by its open access model, enhances the visibility and dissemination of vital research findings, ensuring that every contribution reaches a broad audience. As of 2024, Trials continues to be a crucial resource for anyone passionate about exploring new frontiers in medical research.

Clinical Trials

Exploring the frontiers of clinical innovation.
Publisher: SAGE PUBLICATIONS LTDISSN: 1740-7745Frequency: 6 issues/year

Clinical Trials, published by SAGE Publications Ltd, is a prestigious journal that serves as a vital resource for researchers, professionals, and students in the fields of medicine and pharmacology. Operating since 2004 and converging through 2024, this journal boasts an impressive standing in the academic community, achieving a Q1 categorization in both Medicine (miscellaneous) and Pharmacology as of 2023. The journal's Scopus rankings reflect its influential contributions, with a rank of #128 out of 636 in General Medicine and a 79th percentile placement, alongside a rank of #172 out of 313 in Pharmacology, indicating its significant role in advancing clinical research. Based in the United Kingdom, Clinical Trials focuses on disseminating high-quality studies that enhance the understanding of clinical processes and therapeutic methodologies. Although it does not currently offer Open Access, the journal provides a platform for traditional publication, ensuring the dissemination of critical knowledge in the healthcare domain.

Journal of Survey Statistics and Methodology

Innovating Methodologies for Data-Driven Insights
Publisher: OXFORD UNIV PRESS INCISSN: 2325-0984Frequency: 4 issues/year

Journal of Survey Statistics and Methodology, published by Oxford University Press Inc, is a pivotal platform for advancing research in the fields of Applied Mathematics, Social Sciences, and Statistics. With its ISSN 2325-0984 and E-ISSN 2325-0992, this journal has firmly established itself since its inception in 2013, achieving a remarkable Q1 quartile ranking across various disciplines in 2023, indicating its significant impact and prestige in the academic community. It serves as a key resource for researchers and practitioners committed to enhancing survey methodology, statistical practices, and data-driven decision-making processes. The journal provides a comprehensive assembly of scholarly articles, methodological advancements, and theoretical insights, aimed at enriching the landscape of survey statistics and related domains. Scholars are encouraged to contribute and stay abreast of the latest findings that shape the future of survey research and methodology.

STATISTICS

Elevating the discourse in statistical methodologies and applications.
Publisher: TAYLOR & FRANCIS LTDISSN: 0233-1888Frequency: 6 issues/year

STATISTICS is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of statistical science since its inception in 1985. With a strong focus on both the theoretical and practical aspects of Statistics and Probability, this journal serves as a vital platform for researchers, professionals, and students seeking to disseminate their findings and contribute to critical discussions in the discipline. Although categorized in the Q3 quartile for both Statistics and Probability and Statistics, Probability and Uncertainty, the journal's commitment to quality research is evidenced by its inclusion in relevant Scopus rankings. It holds respectable positions, ranked #132/168 in Decision Sciences and #219/278 in Mathematics. By providing a venue for high-quality research articles and reviews, STATISTICS aims to foster innovation, reinforce methodological advancements, and address contemporary challenges in statistical applications. The journal does not currently offer open access, but it is widely distributed, ensuring that significant research reaches the communities that need it most. Researchers are encouraged to submit their work to this essential resource that continues to shape the landscape of statistical inquiry.

STATISTICS IN MEDICINE

Elevating biomedical research through rigorous statistical dialogue.
Publisher: WILEYISSN: 0277-6715Frequency: 30 issues/year

Statistics in Medicine, published by Wiley, is a prestigious journal dedicated to the advancement of statistical methods and their application in biomedical research. Established in 1982, this journal has become a cornerstone in the fields of Epidemiology and Statistics and Probability, demonstrating its importance by consistently achieving a Q1 ranking in the 2023 category quartiles. With an impressive ISSN of 0277-6715 and an E-ISSN of 1097-0258, it serves as a vital platform for disseminating high-quality research that enhances evidence-based medicine. Although the journal does not currently offer open access, it remains highly regarded, holding a Scopus rank of #66 in Mathematics and #80 in Medicine, indicating its significant impact on the academic community. By publishing cutting-edge research, Statistics in Medicine aims to bridge the gap between statistical theory and practical application in health domains, fostering a rigorous dialogue among researchers, clinicians, and statisticians alike.